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cGMP is generated in blood platelets following activation
of soluble guanylate cyclase (sGC) by nitric oxide (NO).
Once synthesised, cGMP activates cGMP-dependent pro-
tein kinase (PKG) and causes an increase in intracellular
cAMP concentration by inhibiting phosphodiesterase 3
(PDE3), responsible for its degradation. PKG and the
cAMP-dependent protein kinase (PKA) phosphorylate a
number of substrates with inhibitory effects on platelet
function [1]. While NO is mainly generated by endothelial
NO synthase (eNOS) in the endothelium, reduction of
nitrite constitutes an alternative vascular source of NO
during hypoxic and acidic conditions. Nitrite originates
from reduction of dietary nitrate, found in foods such as
beetroot and green leafy vegetables. Nitrite in the circula-
tion can be converted to NO by several nitrite reductases
in blood and tissues [2], and triggers vasodilatation [3]
thus lowering blood pressure [4]. It has also been demon-
strated that when eNOS activity is impaired, NO gener-
ated through the nitrate/nitrite pathway exerts negative
effects on platelet function [5].
Whilst deoxyhaemoglobin is a candidate nitrite-reduc-
tase in blood [6], we aimed to characterise the effects of
nitrite in isolated platelets. As such, we used a preparation
of washed platelets and supraphysiological concentrations
of nitrite in vitro and characterised nitrite-dependent
cGMP generation and inhibition of platelet function.
Our data show that nitrite at high concentrations (1mM)
is a powerful generator of cGMP in platelets in the
absence of extracellular reductases. While cGMP accumu-
lation is inhibited by sGC inhibitor ODQ, NO scavengers
have a partial effect. This seems to indicate that nitrite
acts through both NO-dependent and independent
mechanisms. Accordingly, phosphorylation of the the
cAMP and cGMP-dependent substrate VASP is strongly
increased and, similarly to cGMP generation, is completely
dependent on sGC activity but not NO. The increase of
cGMP induced by high concentrations of nitrite inhibits
platelet function as measured by platelet aggregation and
secretion. However, whilst being dependent on sGC activ-
ity, the effect of nitrite on aggregation is not dependent on
NO.generation. Lower concentrations of nitrite synergise
with inhibition of PDEs, in particular PDE5 responsible for
cGMP degradation, to trigger detectable VASP phosphory-
lation and inhibition of aggregation.
Nitrite triggers generation of cGMP in platelets and
exerts inhibitory effects independently of extracellular
reductases and other blood cells. Nitrite acts partly
through reduction to NO and partly through an unchar-
acterised direct effect on sGC.
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